These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29872154)

  • 21. Elimination of infectious HIV DNA by CRISPR-Cas9.
    Das AT; Binda CS; Berkhout B
    Curr Opin Virol; 2019 Oct; 38():81-88. PubMed ID: 31450074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia.
    Xu L; Wang J; Liu Y; Xie L; Su B; Mou D; Wang L; Liu T; Wang X; Zhang B; Zhao L; Hu L; Ning H; Zhang Y; Deng K; Liu L; Lu X; Zhang T; Xu J; Li C; Wu H; Deng H; Chen H
    N Engl J Med; 2019 Sep; 381(13):1240-1247. PubMed ID: 31509667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biallelic, Selectable, Knock-in Targeting of CCR5
    Scheller SH; Rashad Y; Saleh FM; Willingham KA; Reilich A; Lin D; Izadpanah R; Alt EU; Braun SE
    Front Immunol; 2022; 13():821190. PubMed ID: 35386712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential regulation of CXCR4 and CCR5 expression by interleukin (IL)-4 and IL-13 is associated with inhibition of chemotaxis and human immunodeficiency Virus (HIV) type 1 replication but not HIV entry into human monocytes.
    Creery D; Weiss W; Graziani-Bowering G; Kumar R; Aziz Z; Angel JB; Kumar A
    Viral Immunol; 2006; 19(3):409-23. PubMed ID: 16987060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9.
    Gundry MC; Brunetti L; Lin A; Mayle AE; Kitano A; Wagner D; Hsu JI; Hoegenauer KA; Rooney CM; Goodell MA; Nakada D
    Cell Rep; 2016 Oct; 17(5):1453-1461. PubMed ID: 27783956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concise Review: CXCR4/CXCL12 Signaling in Immature Hematopoiesis--Lessons From Pharmacological and Genetic Models.
    Karpova D; Bonig H
    Stem Cells; 2015 Aug; 33(8):2391-9. PubMed ID: 25966814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The two human CXCR4 isoforms display different HIV receptor activities: consequences for the emergence of X4 strains.
    Duquenne C; Psomas C; Gimenez S; Guigues A; Carles MJ; Barbuat C; Lavigne JP; Sotto A; Reynes J; Guglielmi P; Mettling C; François V; Corbeau P
    J Immunol; 2014 Oct; 193(8):4188-94. PubMed ID: 25230750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Killing two birds with one stone: CRISPR/Cas9 CCR5 knockout hematopoietic stem cells transplantation to treat patients with HIV infection and hematological malignancies concurrently.
    Au TY; Arudkumar J; Assavarittirong C; Benjamin S
    Clin Exp Med; 2023 Dec; 23(8):4163-4175. PubMed ID: 37500934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of HIV-1 infection by down-regulation of the CXCR4 co-receptor using an intracellular single chain variable fragment against CXCR4.
    BouHamdan M; Strayer DS; Wei D; Mukhtar M; Duan LX; Hoxie J; Pomerantz RJ
    Gene Ther; 2001 Mar; 8(5):408-18. PubMed ID: 11313818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing.
    Kaminski R; Chen Y; Fischer T; Tedaldi E; Napoli A; Zhang Y; Karn J; Hu W; Khalili K
    Sci Rep; 2016 Mar; 6():22555. PubMed ID: 26939770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV-1 utilizes the CXCR4 chemokine receptor to infect multipotent hematopoietic stem and progenitor cells.
    Carter CC; McNamara LA; Onafuwa-Nuga A; Shackleton M; Riddell J; Bixby D; Savona MR; Morrison SJ; Collins KL
    Cell Host Microbe; 2011 Mar; 9(3):223-234. PubMed ID: 21402361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Combination of CRISPR/Cas9 and iPSC Technologies in the Gene Therapy of Human β-thalassemia in Mice.
    Ou Z; Niu X; He W; Chen Y; Song B; Xian Y; Fan D; Tang D; Sun X
    Sci Rep; 2016 Sep; 6():32463. PubMed ID: 27581487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic haute couture to block HIV-1 at front doors.
    Ancuta P
    Cell Stem Cell; 2024 Apr; 31(4):433-434. PubMed ID: 38579679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distinct functional sites for human immunodeficiency virus type 1 and stromal cell-derived factor 1alpha on CXCR4 transmembrane helical domains.
    Tian S; Choi WT; Liu D; Pesavento J; Wang Y; An J; Sodroski JG; Huang Z
    J Virol; 2005 Oct; 79(20):12667-73. PubMed ID: 16188969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR/Cas9 genome editing to create nonhuman primate models for studying stem cell therapies for HIV infection.
    Schmidt JK; Reynolds MR; Golos TG; Slukvin II
    Retrovirology; 2022 Aug; 19(1):17. PubMed ID: 35948929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression and function of chemokine receptors on human thymocytes: implications for infection by human immunodeficiency virus type 1.
    Taylor JR; Kimbrell KC; Scoggins R; Delaney M; Wu L; Camerini D
    J Virol; 2001 Sep; 75(18):8752-60. PubMed ID: 11507220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Applications of CRISPR/Cas9 tools in deciphering the mechanisms of HIV-1 persistence.
    Verdikt R; Darcis G; Ait-Ammar A; Van Lint C
    Curr Opin Virol; 2019 Oct; 38():63-69. PubMed ID: 31509794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of HIV-2 chimeric viruses unable to use CCR5 and CXCR4 coreceptors.
    Santos-Costa Q; Mansinho K; Moniz-Pereira J; Azevedo-Pereira JM
    Virus Res; 2009 Jun; 142(1-2):41-50. PubMed ID: 19200444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene Editing in Human Lymphoid Cells: Role for Donor DNA, Type of Genomic Nuclease and Cell Selection Method.
    Zotova A; Lopatukhina E; Filatov A; Khaitov M; Mazurov D
    Viruses; 2017 Nov; 9(11):. PubMed ID: 29099045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells.
    Agrawal L; Lu X; Qingwen J; VanHorn-Ali Z; Nicolescu IV; McDermott DH; Murphy PM; Alkhatib G
    J Virol; 2004 Mar; 78(5):2277-87. PubMed ID: 14963124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.